Literature DB >> 1320098

Infections of the cervix uteri with human papillomavirus and Chlamydia trachomatis.

E C Claas1, W J Melchers, H G Niesters, R van Muyden, E Stolz, W G Quint.   

Abstract

Apart from infection with human papillomavirus (HPV), other microorganisms may be involved in the development of cervical neoplasia. To study concomitant infections with HPV and Chlamydia trachomatis, cervical specimens from 4 groups of women were examined for the presence of these microorganisms by the polymerase chain reaction. The first group consisted of 143 consecutive samples from women with no cytological abnormalities who participated in a triennial screening program to prevent cervical cancer. In this group 2 samples were found positive for HPV and 2 additional samples were found positive for C. trachomatis. In the second group of 46 cytologically abnormal smears, HPV DNA was detected in 71.7% of the samples and C. tra chomatis in 4.3%. In a third group of 94 histological abnormal biopsies, the HPV prevalence ranged from 15% in mild dysplastic lesions up to 92% in invasive cervical carcinomas. Only 2 biopsies of this group (2.1%) were found positive for C. trachomatis. Finally, a group of cervical scrapes was obtained from women attending a clinic for sexually transmitted diseases. In 52 samples positive for C. trachomatis and 60 samples negative for C. trachomatis, no significant (P = 0.57) difference in the frequency of HPV infections was found (11.5% and 8.3%, respectively). The data show that in these study groups HPV and C. trachomatis are independently occurring agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320098     DOI: 10.1002/jmv.1890370109

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Evaluation of an in-house polymerase chain reaction for detection of Neisseria gonorrhoeae in urogenital samples.

Authors:  R Roymans; G Onland; A Jansz; W Quint; E Boel
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

2.  Cervico-vaginal Chlamydia trachomatis infection in pregnant adolescent and adult women. A morphologic and immunofluorescent study.

Authors:  M J Cavaliere; M Y Maeda; N K Shirata; A Longatto Filho; L W Shih; M de Siqueira; M G de Muelenare Correa; H F Oliveira
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

3.  Prevalence of Chlamydia trachomatis endocervical infection in systemic lupus erythematosus patients and evaluation of the risk for HPV-induced lesions.

Authors:  Licia CostaPinto; Viviana Gallazzi Olavarria; Maria Fernanda Rios Grassi; Leomar D' Cirqueira Lyrio; Rone Peterson Cerqueira Oliveira; Iuri Usêda Santana; Cristiane Bahiana Cruz; Mittermayer Barreto Santiago
Journal:  Rheumatol Int       Date:  2012-04-07       Impact factor: 2.631

4.  One-day detection of PCR amplified Chlamydia trachomatis DNA in clinical samples: ELISA versus Southern blot hybridisation.

Authors:  R T Roymans; G Onland; B H Postma
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

5.  Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus.

Authors:  M P Burger; H Hollema; W J Pieters; F P Schröder; W G Quint
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.